Clearance Summary
Continuous Single Culture-NX Complete (CSCM-NXC) received FDA 510(k) clearance under submission number K170602, sponsored by Irvine Scientific Sales Co., Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Obstetrics/Gynecology review panel. The statutory decision date of record is 2017-06-07.
- Submission: K170602
- Applicant / Sponsor: Irvine Scientific Sales Co., Inc.
- Clearance pathway: Traditional
- Review panel: Obstetrics/Gynecology
- Device class: Class II
- Regulation citation: 21 CFR 884.6180
- Decision date: 2017-06-07
Classification & Regulation
This clearance is catalogued under FDA product code MQL and 21 CFR 884.6180, within the Obstetrics/Gynecology review panel as a Class II device.